131 related articles for article (PubMed ID: 37182504)
21. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix.
Lipscombe RJ; Nakhoul AM; Sanderson CJ; Coombe DR
J Leukoc Biol; 1998 Mar; 63(3):342-50. PubMed ID: 9500522
[TBL] [Abstract][Full Text] [Related]
23. The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation.
Skidmore MA; Guimond SE; Rudd TR; Fernig DG; Turnbull JE; Yates EA
Connect Tissue Res; 2008; 49(3):140-4. PubMed ID: 18661329
[TBL] [Abstract][Full Text] [Related]
24. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
[TBL] [Abstract][Full Text] [Related]
25. Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation.
Spanou CES; Wohl AP; Doherr S; Correns A; Sonntag N; Lütke S; Mörgelin M; Imhof T; Gebauer JM; Baumann U; Grobe K; Koch M; Sengle G
FASEB J; 2023 Jan; 37(1):e22717. PubMed ID: 36563024
[TBL] [Abstract][Full Text] [Related]
26. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
27. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
Bashkin P; Razin E; Eldor A; Vlodavsky I
Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
[TBL] [Abstract][Full Text] [Related]
28. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
Shibata S; Sasaki T; Harpel P; Fillit H
Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
[TBL] [Abstract][Full Text] [Related]
30. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
Schoenfeld AK; Vierfuß S; Lühn S; Alban S
J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
[TBL] [Abstract][Full Text] [Related]
31. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
32. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche.
Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
Blood; 1998 Dec; 92(12):4641-51. PubMed ID: 9845530
[TBL] [Abstract][Full Text] [Related]
33. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
[TBL] [Abstract][Full Text] [Related]
34. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
35. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.
Yu WH; Yu S; Meng Q; Brew K; Woessner JF
J Biol Chem; 2000 Oct; 275(40):31226-32. PubMed ID: 10900194
[TBL] [Abstract][Full Text] [Related]
36. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.
Klimstra WB; Ryman KD; Johnston RE
J Virol; 1998 Sep; 72(9):7357-66. PubMed ID: 9696832
[TBL] [Abstract][Full Text] [Related]
37. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95).
Raboudi N; Julian J; Rohde LH; Carson DD
J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862
[TBL] [Abstract][Full Text] [Related]
38. Characterization of annexin A1 glycan binding reveals binding to highly sulfated glycans with preference for highly sulfated heparan sulfate and heparin.
Horlacher T; Noti C; de Paz JL; Bindschädler P; Hecht ML; Smith DF; Fukuda MN; Seeberger PH
Biochemistry; 2011 Apr; 50(13):2650-9. PubMed ID: 21370880
[TBL] [Abstract][Full Text] [Related]
39. Desorption electrospray ionization mass spectrometry of glycosaminoglycans and their protein noncovalent complex.
Przybylski C; Gonnet F; Hersant Y; Bonnaffé D; Lortat-Jacob H; Daniel R
Anal Chem; 2010 Nov; 82(22):9225-33. PubMed ID: 21028826
[TBL] [Abstract][Full Text] [Related]
40. Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides: 2000-Present.
Dulaney SB; Huang X
Adv Carbohydr Chem Biochem; 2021; 80():121-164. PubMed ID: 34872655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
